குழு தலைவர் இல் குழந்தைகள் புற்றுநோய் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குழு தலைவர் இல் குழந்தைகள் புற்றுநோய் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குழு தலைவர் இல் குழந்தைகள் புற்றுநோய் நிறுவனம் Today - Breaking & Trending Today

Study may lead to new treatment for incurable brain cancer in children


Study may lead to new treatment for incurable brain cancer in children
Research by Australian scientists could pave the way to a new treatment for a currently incurable brain cancer in children called Diffuse Intrinsic Pontine Glioma, or DIPG. Affecting about 20 children in Australia each year, DIPG is a devastating disease with an average survival time of just nine months after diagnosis.
The research, led by scientists at Children s Cancer Institute and published this week in the international journal,
Cell Reports, offers an exciting new therapeutic approach for the treatment of DIPG by using a new anti-cancer drug.
The new drug, CBL0137, is an anti-cancer compound developed from the antimalarial drug quinacrine. The researchers found that CBL0137 directly reverses the effects of the key genetic drivers in DIPG, and has a profound effect against DIPG tumor models. ....

New South Wales , David Ziegler , Emily Henderson , Institute Experimental Therapeutics Group , Kids Cancer Centre , Brain Tumors Group At Children Cancer Institute , Group Leader , Group Leader At Children Cancer Institute , Children Cancer Institute , Brain Tumors Group , Diffuse Intrinsic Pontine Glioma , Cancer Institute , Cell Reports , Professor David Ziegler , Sydney Children , Associate Professor , Associate Professor Ziegler , Experimental Therapeutics Group , Prof Ziegler , புதியது தெற்கு வேல்ஸ் , டேவிட் ஸீக்லர் , எமிலி ஹென்டர்சன் , கீட்ஸ் புற்றுநோய் மையம் , குழு தலைவர் , குழு தலைவர் இல் குழந்தைகள் புற்றுநோய் நிறுவனம் , குழந்தைகள் புற்றுநோய் நிறுவனம் ,

Australian researchers find new way to target deadly childhood cancer


 E-Mail
Research by Australian scientists could pave the way to a new treatment for a currently incurable brain cancer in children called Diffuse Intrinsic Pontine Glioma, or DIPG. Affecting about 20 children in Australia each year, DIPG is a devastating disease with an average survival time of just nine months after diagnosis.
The research, led by scientists at Children s Cancer Institute and published this week in the international journal,
Cell Reports, offers an exciting new therapeutic approach for the treatment of DIPG by using a new anti-cancer drug.
The new drug, CBL0137, is an anti-cancer compound developed from the antimalarial drug quinacrine. The researchers found that CBL0137 directly reverses the effects of the key genetic drivers in DIPG, and has a profound effect against DIPG tumour models. They also foundCBL0137 is even more effective when combined with a second drug, panobinostat, a new type of drug known as a histone deacetylase (HDAC) inhib ....

New South Wales , David Ziegler , Institute Experimental Therapeutics Group , National Health , Benny Wills Brain Tumour Research Fund , Group Leader At Children Cancer Institute , Cancer Institute , Brain Tumours Group At Children Cancer Institute , Kids Cancer Centre , Cure Brain Cancer Foundation , Children Cancer Institute , Research Council , Brain Tumours Group , Diffuse Intrinsic Pontine Glioma , Cell Reports , Professor David Ziegler , Group Leader , Sydney Children , Associate Professor Ziegler , Experimental Therapeutics Group , Associate Professor , Prof Ziegler , Medical Research Council , Cure Starts Now , Cancer Project , Benny Wills Brain Tumour Research ,